Paliperidone Palmitate: A Breakthrough Treatment for Schizophrenia? A Review on Patient Adherence Levels, Healthcare Resource Utilization and Costs

International guidelines suggest long-term antipsychotic therapies for treating schizophrenia; however, medication compliance remains a critical issue in schizophrenia. Paliperidone palmitate (PP) is a second-generation antipsychotic long-acting injectable (SGA-LAI) approved for the treatment of sch...

Descripción completa

Detalles Bibliográficos
Autores principales: Bramante, Stefano, Di Salvo, Gabriele, Maina, Giuseppe, Rosso, Gianluca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007865/
https://www.ncbi.nlm.nih.gov/pubmed/36915906
http://dx.doi.org/10.2147/NDT.S374696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007865/
https://www.ncbi.nlm.nih.gov/pubmed/36915906
http://dx.doi.org/10.2147/NDT.S374696

Ejemplares similares